| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 59425 |
|
26,983 |
20,540 |
$2.00M |
| 59426 |
|
22,738 |
11,246 |
$1.64M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
20,837 |
16,729 |
$1.34M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22,098 |
17,250 |
$978K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,501 |
2,947 |
$267K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
3,477 |
2,744 |
$219K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,579 |
2,345 |
$196K |
| 76830 |
Ultrasound, transvaginal |
2,417 |
2,180 |
$163K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
5,908 |
5,016 |
$154K |
| 87799 |
|
3,746 |
3,195 |
$120K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,400 |
1,936 |
$118K |
| 87512 |
|
3,746 |
3,195 |
$117K |
| 87481 |
|
4,139 |
3,518 |
$107K |
| 87482 |
|
3,765 |
3,194 |
$96K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
835 |
727 |
$95K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,323 |
3,718 |
$80K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,854 |
3,312 |
$68K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,110 |
2,773 |
$63K |
| 36415 |
Collection of venous blood by venipuncture |
19,253 |
15,221 |
$60K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,160 |
1,074 |
$59K |
| 90670 |
|
2,337 |
2,113 |
$57K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,564 |
4,021 |
$55K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
579 |
504 |
$47K |
| 59409 |
Vaginal delivery only (with or without episiotomy and/or forceps) |
459 |
421 |
$37K |
| 81513 |
|
374 |
309 |
$34K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,060 |
1,001 |
$32K |
| 59430 |
|
632 |
531 |
$30K |
| 59025 |
Fetal non-stress test |
1,182 |
606 |
$28K |
| 90698 |
|
2,031 |
1,816 |
$21K |
| 90680 |
|
1,755 |
1,571 |
$20K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
230 |
217 |
$18K |
| 90474 |
|
1,410 |
1,272 |
$18K |
| 99381 |
|
208 |
185 |
$17K |
| 99215 |
Prolong outpt/office vis |
544 |
485 |
$16K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
491 |
303 |
$10K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
177 |
154 |
$8K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
467 |
430 |
$8K |
| 99459 |
|
589 |
446 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
627 |
562 |
$8K |
| 99460 |
|
98 |
86 |
$6K |
| 87563 |
|
182 |
142 |
$4K |
| 80081 |
|
597 |
494 |
$4K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
281 |
273 |
$3K |
| 59514 |
|
262 |
204 |
$3K |
| 90685 |
|
144 |
135 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
162 |
135 |
$2K |
| 90686 |
|
1,175 |
1,067 |
$2K |
| 90633 |
|
834 |
743 |
$2K |
| 90744 |
|
935 |
825 |
$2K |
| 86803 |
|
461 |
388 |
$2K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
31 |
27 |
$2K |
| 86592 |
|
1,461 |
1,281 |
$2K |
| 76857 |
|
106 |
91 |
$2K |
| 76820 |
|
347 |
222 |
$2K |
| 36416 |
|
627 |
555 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
536 |
423 |
$2K |
| 85018 |
|
1,479 |
1,297 |
$2K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
158 |
67 |
$2K |
| 99221 |
|
29 |
26 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
14 |
14 |
$1K |
| 81025 |
|
638 |
543 |
$1K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
40 |
36 |
$1K |
| 51701 |
|
51 |
40 |
$973.54 |
| 87660 |
|
1,205 |
1,059 |
$968.87 |
| 87480 |
|
1,206 |
1,059 |
$968.87 |
| 87510 |
|
1,205 |
1,059 |
$968.87 |
| 85027 |
|
341 |
280 |
$888.79 |
| 87081 |
|
209 |
194 |
$882.98 |
| 82947 |
|
693 |
438 |
$731.00 |
| 90723 |
|
69 |
65 |
$694.41 |
| 81001 |
|
668 |
582 |
$644.85 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
156 |
150 |
$632.44 |
| 99173 |
|
421 |
405 |
$611.84 |
| 82950 |
|
734 |
641 |
$507.01 |
| 90715 |
|
350 |
329 |
$478.08 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
68 |
26 |
$469.20 |
| 90674 |
|
15 |
13 |
$464.98 |
| 81003 |
|
873 |
733 |
$385.96 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
44 |
44 |
$364.77 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
249 |
217 |
$349.52 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
66 |
63 |
$325.49 |
| 90716 |
|
190 |
170 |
$263.05 |
| 58300 |
|
189 |
145 |
$261.69 |
| 97597 |
|
41 |
14 |
$225.69 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
103 |
74 |
$189.08 |
| 87430 |
|
17 |
12 |
$170.24 |
| 96127 |
|
57 |
52 |
$165.02 |
| 90707 |
|
196 |
172 |
$158.97 |
| 87340 |
|
248 |
215 |
$137.28 |
| 90648 |
|
55 |
53 |
$93.79 |
| 99385 |
|
137 |
133 |
$71.02 |
| 84443 |
Thyroid stimulating hormone (TSH) |
363 |
290 |
$11.22 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
317 |
311 |
$0.00 |
| 84702 |
|
431 |
263 |
$0.00 |
| 84439 |
|
143 |
112 |
$0.00 |
| 84146 |
|
13 |
12 |
$0.00 |
| 90756 |
|
15 |
14 |
$0.00 |
| 99354 |
|
329 |
271 |
$0.00 |
| 90671 |
|
53 |
50 |
$0.00 |
| 11982 |
|
13 |
13 |
$0.00 |
| 58611 |
|
13 |
12 |
$0.00 |
| 90710 |
|
15 |
12 |
$0.00 |
| 86900 |
|
14 |
12 |
$0.00 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
613 |
573 |
$0.00 |
| 90688 |
|
30 |
27 |
$0.00 |
| 90697 |
|
150 |
138 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
74 |
61 |
$0.00 |
| 76801 |
|
116 |
107 |
$0.00 |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
74 |
53 |
$0.00 |
| 58301 |
|
26 |
25 |
$0.00 |
| 90656 |
|
21 |
19 |
$0.00 |
| 58100 |
|
54 |
52 |
$0.00 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
201 |
168 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
12 |
12 |
$0.00 |
| 82951 |
|
27 |
27 |
$0.00 |
| 82952 |
|
26 |
26 |
$0.00 |
| J2791 |
Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu |
12 |
12 |
$0.00 |
| 90696 |
|
15 |
12 |
$0.00 |
| 99205 |
Prolong outpt/office vis |
16 |
14 |
$0.00 |
| 86901 |
|
14 |
12 |
$0.00 |